Subscribe to news

HSCI’s Board of Directors Has Recommended the Annual Dividends for 2013

Moscow – 21 May 2014.   The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced the decision of the Company’s Board of Directors to recommend the following annual dividends for 2013 to the Annual General Shareholder’s Meeting:

    • RUB 0.15 per ordinary share;
    • The total amount of the proposed dividends for 2013 is RUB 11.250 million or 98% of the Company’s 2013 net profit under RAS.

In accordance with the decision of the HSCI’s Board of Directors to be approved at the AGM, shareholders of record on June 30, 2014 will be entitled to receive dividends for 2013.

On June 17, 2014 the AGM, to be held at 11 a. m. (Moscow time) at the Ladoga hall of Renaissance Moscow Hotel located at 18/1, Olympiysky prospect, Moscow, Russian Federation, will determine dividend payments and the record date for receiving dividends.
 

Full Version of the Press Release (212 kb)


21 May 2014